ALCAM: A Novel Surface Marker on EpCAM<sup>low</sup> Circulating Tumor Cells
<b>Background:</b> Current strategies in circulating tumor cell (CTC) isolation in pancreatic cancer heavily rely on the EpCAM and cytokeratin cell status. EpCAM is generally not considered a good marker given its transitory change during Epithelial to Mesenchymal Transition (EMT) or rev...
Main Authors: | Rossana Signorelli, Teresa Maidana Giret, Oliver Umland, Marco Hadisurya, Shweta Lavania, John Lalith Charles Richard, Ashley Middleton, Melinda Minucci Boone, Ayse Burcu Ergonul, Weiguo Andy Tao, Haleh Amirian, Anton Iliuk, Aliya Khan, Robert Diaz, Daniel Bilbao Cortes, Monica Garcia-Buitrago, Harrys Kishore Charles Jacob |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/8/1983 |
Similar Items
-
Circulating CEA‐positive and EpCAM‐negative tumor cells might be a predictive biomarker for recurrence in patients with gastric cancer
by: Yuichiro Miki, et al.
Published: (2021-01-01) -
CRISPR-surfaceome: An online tool for designing highly efficient sgRNAs targeting cell surface proteins
by: Hong Mei, et al.
Published: (2022-01-01) -
The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets
by: Martina Rossi, et al.
Published: (2021-07-01) -
Multi-Omics Integrative Approach of Extracellular Vesicles: A Future Challenging Milestone
by: Enxhi Shaba, et al.
Published: (2022-04-01) -
Unraveling the surface proteomic profile of multiple
myeloma to reveal new immunotherapeutic targets and markers of drug resistance
by: Bonell Patiño-Escobar, et al.
Published: (2022-11-01)